1.5 CE Credits
Anthony C. Ruocco, Ph.D.
Associate Professor of Psychology, University of Toronto
Clinical Psychology Program Coordinator, University of Toronto
Collaborator Scientist, Mood & Anxiety Division, Centre for Addiction & Mental Health
Cognitive deficits are a common feature of many mental disorders. Neuropsychologists are frequently called upon to evaluate cognition in these patients and make clinical decisions about the relevance of cognitive deficits to the patient’s everyday functioning and treatment approach. This webinar reviews the clinical utility of neuropsychological testing for patients with mental disorders, including depression, schizophrenia, and borderline personality disorder. The focus is on providing information on the cognitive deficits normally observed in common mental disorders and discussing how neuropsychological testing can be used to inform a variety of clinical decisions, including differential diagnosis, development of intervention approaches, and assessment of functional disability.
After the webinar, participants will be able to:
- Describe patterns of cognitive strengths and weaknesses that are normally observed in patients with mental disorders.
- Apply this knowledge to inform diagnostic formulations and intervention approaches.
- Discuss how cognitive deficits can lead to functional disability in patients with mental disorders.
Target Audience: The presentation is appropriate for practicing psychologists and researchers, as well as trainees.
NAN members login and non-members create an account to:
Instructional Level: Intermediate
About Anthony C. Ruocco, Ph.D.
Dr. Ruocco is an Associate Professor of Psychology and the Clinical Psychology Program Coordinator at the University of Toronto. He is a licensed psychologist and researcher with interests in cognition and neuroimaging in patients with mental disorders. His current research program focuses on borderline personality disorder, including the familial aggregation of cognitive deficits, prediction of treatment outcomes using cognition and neuroimaging, and the impacts of a novel brain stimulation on symptoms, cognition and brain systems underlying impulse control and emotion regulation. His research is supported by grants from the Canadian Institutes of Health Research, Brain & Behavior Research Foundation, American Foundation for Suicide Prevention, and the Province of Ontario’s Ministry of Research & Innovation.